Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| HCA Healthcare, Inc.HCA · Entity 2929 | SVP and CIO | April 12, 2023 | April 14, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
HCA Healthcare, Inc.
Report date April 12, 2023 · Filed April 14, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 24,643 |
Ending reported balance
After 2023-04-14 transaction · row 3
3 source rows · reconciled sequenceRow 1 · 2023-04-12 · Exercise / conversion · Acquired 6,340 · Balance 30,983 F1: The exercise of stock appreciation rights and sale of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 10, 2022. Row 2 · 2023-04-12 · Tax withholding · Disposed 3,653 · Balance 27,330 F1: The exercise of stock appreciation rights and sale of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 10, 2022. Row 3 · 2023-04-14 · Sale · Disposed 2,687 · Balance 24,643 F1: The exercise of stock appreciation rights and sale of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 10, 2022. |
| Stock Appreciation RightSEC Table II · derivative / convertible security · Conversion / exercise price $81.96 · Expires 2027-02-01 | Direct | 0 |
Reported balance
After 2023-04-12 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2023-04-12 · Exercise / conversion · Disposed 6,340 · Balance 0 F1: The exercise of stock appreciation rights and sale of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 10, 2022. F2: The stock appreciation rights vested in four equal annual installments beginning on February 1, 2018. |
| Common StockSEC Table I · non-derivative | Indirectby 2021 Trust | 3,000 |
Reported balance
Holding disclosure · report date 2023-04-12 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 3,000 |
| Common StockSEC Table I · non-derivative | IndirectBy PMP 2020 Trust | 60,000 |
Reported balance
Holding disclosure · report date 2023-04-12 · row 5
Holding and transaction disclosures are not merged.
1 source rowRow 5 · Balance 60,000 |
| Common StockSEC Table I · non-derivative | Indirectby RJP 2020 Trust | 63,999 |
Reported balance
Holding disclosure · report date 2023-04-12 · row 6
Holding and transaction disclosures are not merged.
1 source rowRow 6 · Balance 63,999 |
Filing footnotes · ownership attribution and instrument terms
F1: The exercise of stock appreciation rights and sale of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 10, 2022.
F2: The stock appreciation rights vested in four equal annual installments beginning on February 1, 2018.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 14, 2023 Filed Apr 14, 2023 17:51 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | SaleCommon Stock | 2,687 | $275.00 | $738,925.00 |
DisclosureSEC source: 0001209191-23-024369 · doc4.xml · nonDerivative · entry 3 Paslick P. Martin · CIK 0001551011 · SVP and CIO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,643 F1 · kind: The exercise of stock appreciation rights and sale of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 10, 2022. Read SEC document |
| April 12, 2023 Filed Apr 14, 2023 17:51 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionStock Appreciation Right · Derivative | 6,340 | $0.00 Strike: $81.96 | $0.00 |
DisclosureSEC source: 0001209191-23-024369 · doc4.xml · derivative · entry 7 Paslick P. Martin · CIK 0001551011 · SVP and CIO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,340 shares Expires 2027-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise of stock appreciation rights and sale of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 10, 2022. F2 · derivative.exercise_date: The stock appreciation rights vested in four equal annual installments beginning on February 1, 2018. Read SEC document |
| April 12, 2023 Filed Apr 14, 2023 17:51 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Tax withholdingCommon Stock | 3,653 | $272.38 | $995,004.14 |
DisclosureSEC source: 0001209191-23-024369 · doc4.xml · nonDerivative · entry 2 Paslick P. Martin · CIK 0001551011 · SVP and CIO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,330 F1 · kind: The exercise of stock appreciation rights and sale of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 10, 2022. Read SEC document |
| April 12, 2023 Filed Apr 14, 2023 17:51 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionCommon Stock | 6,340 | $81.96 | $519,626.40 |
DisclosureSEC source: 0001209191-23-024369 · doc4.xml · nonDerivative · entry 1 Paslick P. Martin · CIK 0001551011 · SVP and CIO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,983 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise of stock appreciation rights and sale of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 10, 2022. Read SEC document |
| April 10, 2023 Filed Apr 12, 2023 18:23 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | SaleCommon Stock | 2,539 | $270.00 | $685,530.00 |
DisclosureSEC source: 0001209191-23-024164 · doc4.xml · nonDerivative · entry 1 Paslick P. Martin · CIK 0001551011 · SVP and CIO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,643 F1 · kind: The sale of shares reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 10, 2022. Read SEC document |
| April 05, 2023 Filed Apr 6, 2023 18:26 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionStock Appreciation Right · Derivative | 6,000 | $0.00 Strike: $81.96 | $0.00 |
DisclosureSEC source: 0001209191-23-023644 · doc4.xml · derivative · entry 7 Paslick P. Martin · CIK 0001551011 · SVP and CIO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,340 Underlying: Common Stock · 6,000 shares Expires 2027-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise of stock appreciation rights and sale of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 10, 2022. F2 · derivative.exercise_date: The stock appreciation rights vested in four equal annual installments beginning on February 1, 2018. Read SEC document |
| April 05, 2023 Filed Apr 6, 2023 18:26 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Tax withholdingCommon Stock | 3,461 | $271.31 | $939,003.91 |
DisclosureSEC source: 0001209191-23-023644 · doc4.xml · nonDerivative · entry 3 Paslick P. Martin · CIK 0001551011 · SVP and CIO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,182 F1 · kind: The exercise of stock appreciation rights and sale of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 10, 2022. Read SEC document |
| April 05, 2023 Filed Apr 6, 2023 18:26 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionCommon Stock | 6,000 | $81.96 | $491,760.00 |
DisclosureSEC source: 0001209191-23-023644 · doc4.xml · nonDerivative · entry 2 Paslick P. Martin · CIK 0001551011 · SVP and CIO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,643 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise of stock appreciation rights and sale of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 10, 2022. Read SEC document |
| April 04, 2023 Filed Apr 6, 2023 18:26 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | SaleCommon Stock | 3,034 | $265.00 | $804,010.00 |
DisclosureSEC source: 0001209191-23-023644 · doc4.xml · nonDerivative · entry 1 Paslick P. Martin · CIK 0001551011 · SVP and CIO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,643 F1 · kind: The exercise of stock appreciation rights and sale of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 10, 2022. Read SEC document |
| February 17, 2023 Filed Feb 22, 2023 20:08 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Tax withholdingCommon Stock | 3,589 | $262.84 | $943,332.76 |
DisclosureSEC source: 0001209191-23-012005 · doc4.xml · nonDerivative · entry 2 Paslick P. Martin · CIK 0001551011 · SVP and CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,677 Read SEC document |
| February 17, 2023 Filed Feb 22, 2023 20:08 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GrantCommon Stock | 9,120 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-012005 · doc4.xml · nonDerivative · entry 1 Paslick P. Martin · CIK 0001551011 · SVP and CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,266 F1 · kind: On January 29, 2020, the reporting person was granted 4,560 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2020-2022. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2020-2022 earnings per share, the number of performance share units that vested equaled 200% of the units granted. Read SEC document |
| February 01, 2023 Filed Feb 1, 2023 20:03 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | SaleCommon Stock | 1,000 | $256.95 | $256,948.70 |
DisclosureSEC source: 0001209191-23-006039 · doc4.xml · nonDerivative · entry 1 Paslick P. Martin · CIK 0001551011 · SVP and CIO 10b5-1 filing: Not disclosed Ownership: Indirect · by 2021 Trust Disclosed balance after: 3,000 Read SEC document |
| January 30, 2023 Filed Feb 1, 2023 20:03 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GrantStock Appreciation Right · Derivative | 9,472 | $0.00 Strike: $253.30 | $0.00 |
DisclosureSEC source: 0001209191-23-006039 · doc4.xml · derivative · entry 5 Paslick P. Martin · CIK 0001551011 · SVP and CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,472 Underlying: Common Stock · 9,472 shares Expires 2033-01-30 F1 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on January 30, 2024. Read SEC document |
| January 23, 2023 Filed Jan 25, 2023 19:03 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionStock Appreciation Right · Derivative | 6,000 | $0.00 Strike: $81.96 | $0.00 |
DisclosureSEC source: 0001209191-23-004910 · doc4.xml · derivative · entry 6 Paslick P. Martin · CIK 0001551011 · SVP and CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,340 Underlying: Common Stock · 6,000 shares Expires 2027-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise of stock appreciation rights reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · derivative.exercise_date: The stock appreciation rights vested in four equal annual installments beginning on February 1, 2018. Read SEC document |
| January 23, 2023 Filed Jan 25, 2023 19:03 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Tax withholdingCommon Stock | 2,966 | $263.81 | $782,460.46 |
DisclosureSEC source: 0001209191-23-004910 · doc4.xml · nonDerivative · entry 2 Paslick P. Martin · CIK 0001551011 · SVP and CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,146 F1 · kind: The exercise of stock appreciation rights reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| January 23, 2023 Filed Jan 25, 2023 19:03 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionCommon Stock | 6,000 | $81.96 | $491,760.00 |
DisclosureSEC source: 0001209191-23-004910 · doc4.xml · nonDerivative · entry 1 Paslick P. Martin · CIK 0001551011 · SVP and CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,112 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise of stock appreciation rights reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| February 18, 2022 Filed Feb 23, 2022 19:18 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Tax withholdingCommon Stock | 3,046 | $244.10 | $743,528.60 |
DisclosureSEC source: 0001209191-22-012415 · doc4.xml · nonDerivative · entry 2 Paslick P. Martin · CIK 0001551011 · SVP and CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,112 Read SEC document |
| February 18, 2022 Filed Feb 23, 2022 19:18 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GrantCommon Stock | 9,280 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-012415 · doc4.xml · nonDerivative · entry 1 Paslick P. Martin · CIK 0001551011 · SVP and CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,158 F1 · kind: On January 30, 2019, the reporting person was granted 4,640 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2019-2021. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2019-2021 earnings per share, the number of performance share units that vested equaled 200% of the units granted. Read SEC document |
| January 28, 2022 Filed Feb 1, 2022 19:32 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GrantStock Appreciation Right · Derivative | 10,400 | $0.00 Strike: $236.61 | $0.00 |
DisclosureSEC source: 0001209191-22-006082 · doc4.xml · derivative · entry 6 Paslick P. Martin · CIK 0001551011 · SVP and CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,400 Underlying: Common Stock · 10,400 shares Expires 2032-01-28 F1 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on January 28, 2023. Read SEC document |
| November 12, 2021 Filed Feb 1, 2022 19:32 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GiftCommon Stock | 4,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-006082 · doc4.xml · nonDerivative · entry 4 Paslick P. Martin · CIK 0001551011 · SVP and CIO 10b5-1 filing: Not disclosed Ownership: Indirect · by 2021 Trust Disclosed balance after: 4,000 Read SEC document |
| November 12, 2021 Filed Feb 1, 2022 19:32 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GiftCommon Stock | 4,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-006082 · doc4.xml · nonDerivative · entry 3 Paslick P. Martin · CIK 0001551011 · SVP and CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,878 Read SEC document |
| November 11, 2021 Filed Feb 1, 2022 19:32 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GiftCommon Stock | 4,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-006082 · doc4.xml · nonDerivative · entry 2 Paslick P. Martin · CIK 0001551011 · SVP and CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,878 Read SEC document |
| November 11, 2021 Filed Feb 1, 2022 19:32 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GiftCommon Stock | 4,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-006082 · doc4.xml · nonDerivative · entry 1 Paslick P. Martin · CIK 0001551011 · SVP and CIO 10b5-1 filing: Not disclosed Ownership: Indirect · By PMP 2020 Trust Disclosed balance after: 60,000 Read SEC document |
| July 27, 2021 Filed Jul 29, 2021 18:34 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | SaleCommon Stock | 7,466 | $250.00 | $1,866,500.00 |
DisclosureSEC source: 0001209191-21-048657 · doc4.xml · nonDerivative · entry 1 Paslick P. Martin · CIK 0001551011 · SVP and CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,878 Read SEC document |
| July 21, 2021 Filed Jul 23, 2021 19:19 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionStock Appreciation Right · Derivative | 17,080 | $0.00 Strike: $69.58 | $0.00 |
DisclosureSEC source: 0001209191-21-048073 · doc4.xml · derivative · entry 5 Paslick P. Martin · CIK 0001551011 · SVP and CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 17,080 shares Expires 2026-01-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock appreciation rights vested in four equal annual installments beginning on January 29, 2017. Read SEC document |
| July 21, 2021 Filed Jul 23, 2021 19:19 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Tax withholdingCommon Stock | 9,614 | $249.25 | $2,396,289.50 |
DisclosureSEC source: 0001209191-21-048073 · doc4.xml · nonDerivative · entry 2 Paslick P. Martin · CIK 0001551011 · SVP and CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,344 Read SEC document |
| July 21, 2021 Filed Jul 23, 2021 19:19 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionCommon Stock | 17,080 | $69.58 | $1,188,426.40 |
DisclosureSEC source: 0001209191-21-048073 · doc4.xml · nonDerivative · entry 1 Paslick P. Martin · CIK 0001551011 · SVP and CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,958 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 06, 2021 Filed May 6, 2021 19:55 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | SaleCommon Stock | 7,672 | $207.55 | $1,592,323.60 |
DisclosureSEC source: 0001209191-21-030750 · doc4.xml · nonDerivative · entry 3 Paslick P. Martin · CIK 0001551011 · SVP and CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,878 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $207.51 to $207.88, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 04, 2021 Filed May 6, 2021 19:55 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionStock Appreciation Right · Derivative | 19,000 | $0.00 Strike: $68.96 | $0.00 |
DisclosureSEC source: 0001209191-21-030750 · doc4.xml · derivative · entry 6 Paslick P. Martin · CIK 0001551011 · SVP and CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 19,000 shares Expires 2025-02-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock appreciation rights vested in four equal annual installments beginning on February 4, 2016. Read SEC document |
| May 04, 2021 Filed May 6, 2021 19:55 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Tax withholdingCommon Stock | 11,328 | $206.34 | $2,337,419.52 |
DisclosureSEC source: 0001209191-21-030750 · doc4.xml · nonDerivative · entry 2 Paslick P. Martin · CIK 0001551011 · SVP and CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,550 Read SEC document |
| May 04, 2021 Filed May 6, 2021 19:55 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionCommon Stock | 19,000 | $68.96 | $1,310,240.00 |
DisclosureSEC source: 0001209191-21-030750 · doc4.xml · nonDerivative · entry 1 Paslick P. Martin · CIK 0001551011 · SVP and CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,878 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 18, 2021 Filed Feb 22, 2021 20:42 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Tax withholdingCommon Stock | 4,788 | $174.61 | $836,032.68 |
DisclosureSEC source: 0001209191-21-013001 · doc4.xml · nonDerivative · entry 2 Paslick P. Martin · CIK 0001551011 · SVP and CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,878 Read SEC document |
| February 18, 2021 Filed Feb 22, 2021 20:42 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GrantCommon Stock | 12,166 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-013001 · doc4.xml · nonDerivative · entry 1 Paslick P. Martin · CIK 0001551011 · SVP and CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,666 F1 · kind: On January 31, 2018, the reporting person was granted 7,470 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2018-2020. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 80% of target) to two times the units granted (for actual performance of 120% or more of target). Based upon the Company's achievement with respect to cumulative 2018-2020 earnings per share, the number of performance share units that vested equaled 162.88% of the units granted. Read SEC document |
| February 04, 2021 Filed Feb 5, 2021 20:29 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionStock Appreciation Right · Derivative | 10,525 | $0.00 Strike: $47.97 | $0.00 |
DisclosureSEC source: 0001209191-21-008349 · doc4.xml · derivative · entry 6 Paslick P. Martin · CIK 0001551011 · SVP and CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,525 shares Expires 2024-02-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock appreciation rights vested in four equal annual installments beginning on February 5, 2015. Read SEC document |
| February 04, 2021 Filed Feb 5, 2021 20:29 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Tax withholdingCommon Stock | 5,025 | $179.30 | $900,982.50 |
DisclosureSEC source: 0001209191-21-008349 · doc4.xml · nonDerivative · entry 2 Paslick P. Martin · CIK 0001551011 · SVP and CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,500 Read SEC document |
| February 04, 2021 Filed Feb 5, 2021 20:29 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionCommon Stock | 10,525 | $47.97 | $504,884.25 |
DisclosureSEC source: 0001209191-21-008349 · doc4.xml · nonDerivative · entry 1 Paslick P. Martin · CIK 0001551011 · SVP and CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,525 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 03, 2021 Filed Feb 5, 2021 20:29 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GrantStock Appreciation Right · Derivative | 15,690 | $0.00 Strike: $173.12 | $0.00 |
DisclosureSEC source: 0001209191-21-008349 · doc4.xml · derivative · entry 5 Paslick P. Martin · CIK 0001551011 · SVP and CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,690 Underlying: Common Stock · 15,690 shares Expires 2031-02-03 F1 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on February 3, 2022. Read SEC document |
| November 16, 2020 Filed Nov 17, 2020 20:20 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | SaleCommon Stock | 3,770 | $151.75 | $572,097.50 |
DisclosureSEC source: 0001209191-20-058917 · doc4.xml · nonDerivative · entry 8 Paslick P. Martin · CIK 0001551011 · SVP and CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| November 13, 2020 Filed Nov 17, 2020 20:20 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | SaleCommon Stock | 319 | $149.47 | $47,680.93 |
DisclosureSEC source: 0001209191-20-058917 · doc4.xml · nonDerivative · entry 7 Paslick P. Martin · CIK 0001551011 · SVP and CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,770 Read SEC document |
| November 13, 2020 Filed Nov 17, 2020 20:20 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GiftCommon Stock | 63,999 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-058917 · doc4.xml · nonDerivative · entry 6 Paslick P. Martin · CIK 0001551011 · SVP and CIO 10b5-1 filing: Not disclosed Ownership: Indirect · by RJP 2020 Trust Disclosed balance after: 63,999 Read SEC document |
| November 13, 2020 Filed Nov 17, 2020 20:20 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GiftCommon Stock | 63,999 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-058917 · doc4.xml · nonDerivative · entry 5 Paslick P. Martin · CIK 0001551011 · SVP and CIO 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 0 Read SEC document |
| November 13, 2020 Filed Nov 17, 2020 20:20 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GiftCommon Stock | 64,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-058917 · doc4.xml · nonDerivative · entry 4 Paslick P. Martin · CIK 0001551011 · SVP and CIO 10b5-1 filing: Not disclosed Ownership: Indirect · By PMP 2020 Trust Disclosed balance after: 64,000 Read SEC document |
| November 13, 2020 Filed Nov 17, 2020 20:20 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GiftCommon Stock | 64,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-058917 · doc4.xml · nonDerivative · entry 3 Paslick P. Martin · CIK 0001551011 · SVP and CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,089 Read SEC document |
| November 12, 2020 Filed Nov 17, 2020 20:20 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GiftCommon Stock | 64,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-058917 · doc4.xml · nonDerivative · entry 2 Paslick P. Martin · CIK 0001551011 · SVP and CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,089 Read SEC document |
| November 12, 2020 Filed Nov 17, 2020 20:20 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GiftCommon Stock | 64,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-058917 · doc4.xml · nonDerivative · entry 1 Paslick P. Martin · CIK 0001551011 · SVP and CIO 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 63,999 Read SEC document |
| November 09, 2020 Filed Nov 9, 2020 21:11 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | SaleCommon Stock | 3,948 | $148.07 | $584,583.12 |
DisclosureSEC source: 0001209191-20-057536 · doc4.xml · nonDerivative · entry 3 Paslick P. Martin · CIK 0001551011 · SVP and CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $147.94 to $148.17, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 09, 2020 Filed Nov 12, 2020 20:38 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionStock Appreciation Right · Derivative | 10,000 | $0.00 Strike: $47.97 | $0.00 |
DisclosureSEC source: 0001209191-20-058186 · doc4.xml · derivative · entry 4 Paslick P. Martin · CIK 0001551011 · SVP and CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,525 Underlying: Common Stock · 10,000 shares Expires 2024-02-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock appreciation rights vested in four equal annual installments beginning on February 5, 2015. Read SEC document |
| November 09, 2020 Filed Nov 12, 2020 20:38 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Tax withholdingCommon Stock | 5,911 | $147.32 | $870,808.52 |
DisclosureSEC source: 0001209191-20-058186 · doc4.xml · nonDerivative · entry 2 Paslick P. Martin · CIK 0001551011 · SVP and CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,089 Read SEC document |
| November 09, 2020 Filed Nov 12, 2020 20:38 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionCommon Stock | 10,000 | $47.97 | $479,700.00 |
DisclosureSEC source: 0001209191-20-058186 · doc4.xml · nonDerivative · entry 1 Paslick P. Martin · CIK 0001551011 · SVP and CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 05, 2020 Filed Nov 9, 2020 21:11 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionStock Appreciation Right · Derivative | 3,025 | $0.00 Strike: $47.97 | $0.00 |
DisclosureSEC source: 0001209191-20-057536 · doc4.xml · derivative · entry 6 Paslick P. Martin · CIK 0001551011 · SVP and CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,025 shares Expires 2024-02-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The stock appreciation rights vested at the end of fiscal years 2014, 2015, 2016 and 2017 based upon the achievement of certain annual EBITDA performance targets. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.